Chlorogenic acid (and its metabolite dihydrocaffeic acid) administered either before or after ischemia reduced brain infarct volume, BBB damage and behavioral deficits in tMCAO rats by blunting MMP activation and increasing brain levels of EPO, HIF-1a and nerve growth factor (NGF) [240,241,242]. The gene discussed is EPO; the disease is brain infarction.